Colgate-Palmolive (NYSE:CL) Cut to “Hold” at StockNews.com

Colgate-Palmolive (NYSE:CL) was downgraded by equities researchers at StockNews.com from a “buy” rating to a “hold” rating in a note issued to investors on Thursday.

CL has been the subject of a number of other research reports. Piper Sandler dropped their price objective on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research report on Monday. Stifel Nicolaus lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and cut their price objective for the company from $105.00 to $101.00 in a research report on Monday, October 28th. TD Cowen cut their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research report on Wednesday. JPMorgan Chase & Co. raised their target price on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. Finally, Wells Fargo & Company cut their price target on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a report on Tuesday. One analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat.com, Colgate-Palmolive presently has an average rating of “Hold” and an average price target of $103.63.

Colgate-Palmolive Stock Performance

CL stock remained flat at $87.39 on Thursday. The company had a trading volume of 5,063,919 shares, compared to its average volume of 4,441,603. The firm’s 50-day moving average price is $92.76 and its two-hundred day moving average price is $98.15. The company has a market capitalization of $71.40 billion, a P/E ratio of 25.04, a P/E/G ratio of 3.31 and a beta of 0.44. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a 12-month low of $79.69 and a 12-month high of $109.30.

Insider Buying and Selling

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the company’s stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the transaction, the chief financial officer now owns 36,726 shares in the company, valued at $3,456,283.86. This represents a 55.29 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.34% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in CL. Northcape Capital Pty Ltd grew its holdings in Colgate-Palmolive by 4.9% during the 4th quarter. Northcape Capital Pty Ltd now owns 6,012 shares of the company’s stock valued at $547,000 after purchasing an additional 282 shares in the last quarter. Range Financial Group LLC boosted its position in Colgate-Palmolive by 117.8% in the 4th quarter. Range Financial Group LLC now owns 10,436 shares of the company’s stock valued at $949,000 after buying an additional 5,644 shares during the last quarter. Bath Savings Trust Co grew its stake in shares of Colgate-Palmolive by 2.9% during the fourth quarter. Bath Savings Trust Co now owns 58,137 shares of the company’s stock valued at $5,285,000 after acquiring an additional 1,655 shares in the last quarter. Diversified Trust Co lifted its stake in shares of Colgate-Palmolive by 2.6% in the fourth quarter. Diversified Trust Co now owns 83,360 shares of the company’s stock worth $7,578,000 after acquiring an additional 2,125 shares in the last quarter. Finally, Canandaigua National Bank & Trust Co. boosted its holdings in Colgate-Palmolive by 3.4% in the fourth quarter. Canandaigua National Bank & Trust Co. now owns 12,534 shares of the company’s stock valued at $1,139,000 after purchasing an additional 412 shares during the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.